- Home
- / CordenPharma
CordenPharma
Revenue
$16.2 M
FY, 2020
CordenPharma Summary
Company Summary
- Overview
- CordenPharma is a contract development and manufacturing (CDMO) company. It offers oral formulation tablets and capsules, veterinary oral formulation, sterile solutions and emulsions, pharma packaging, lyophilized vials, etc.
- Type
- Private
- Status
- Active
- Founded
- 2006
- HQ
- Plankstadt, DE | view all locations
- Website
- https://cordenpharma.com/
- Cybersecurity rating
Table of Contents
Key People
Gary Hughes, Chief Financial Officer, CordenPharma
William Cashin, Chief Quality & Compliance Officer, CordenPharma
Lee Newton, Chief Operating Officer, CordenPharma
Operating MetricsView all
Patents (US)
2
Feb, 2022
Patent Applications (US)
1
Feb, 2022
LocationsView all
12 locations detected
Plankstadt, BW HQ
Germany
Otto-Hahn-Str.
Boulder, CO
United States
2075 55th St
Boulder, CO
United States
4876 Sterling Dr
Bruxelles, Bruxelles
Belgium
Rue de Ransbeek 310
Chenôve, Bourgogne-Franche-Comté
France
47 Rue de Longvic
Ilsfeld, BW
Germany
Parkweg 4
CordenPharma Financials
Summary Financials
- Revenue (FY, 2020)
- $16.2M
- Gross profit (FY, 2020)
- $16.0M
- Net income (FY, 2020)
- $493.0K
- Cash (FY, 2020)
- €669.0K